Patients with mastocytosis mostly had similar rates of atopy and allergies as the general population, except for certain conditions such as asthma. While patients with mastocytosis (both systemic [SM] ...

ADI-001 therapy demonstrated a strong safety profile with low rates of cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome. Researchers have developed a novel T-cell ...

Mepolizumab is a new therapeutic that holds potential in improving clinical outcomes in EGPA both safety and effectively. Researchers found that mepolizumab is useful in aiding disease control in ...

Dr. Vishnevetsky is heading a groundbreaking clinical trial of the cannabinoid spray nabiximols for treating the symptoms of NMOSD. Larry Luxner, senior correspondent for Rare Disease Advisor, ...

Closeup of cannabis leaves and flowers at the Curio Wellness grow facility in Timonium, Maryland (Photo by Larry Luxner) Massachusetts General Hospital is formalizing federal approvals to test a ...

IgG4-RD of the breast is rare but should be considered a differential diagnosis if biopsies rule out cancer. Immunoglobulin G4-related disease of the breast (IgG4-BD) is rare but should be considered ...

Which of the statements below about the facts of hemolytic disease of the fetus and newborn (HDFN) are correct? Select one of the options for each question, then submit your answers to see how well ...

Columnist with cold agglutinin disease (CAD) discusses how AI might benefit the diagnosis and treatment of CAD and other rare diseases. Test Your Knowledge About the Diagnosis of CAD Test Your ...

I’ve had COVID-19 before and it’s not an easy disease to fight off especially since I have limb-girdle muscular dystrophy (LGMD) and a tracheotomy. Test Your Knowledge About the Comorbidities of DMD ...

Specific biology therapy can be quite effective in patients with indolent SM. A young woman with indolent systemic mastocytosis (ISM), a subtype of systemic mastocytosis (SM), and concurrent ...

Results showed that patients on efgartigimod had evidence of clinical improvement and a decreased risk of relapse compared to those on placebo. Patients with chronic inflammatory demyelinating ...

Test Your Knowledge About the Surgical Management of Myasthenia Gravis Test Your Knowledge About the Histology of Myasthenia Gravis Test Your Knowledge About the Clinical Features of Myasthenia Gravis ...